Burger, M. C., Forster, M., Romanski, A., Straßheimer, F., Macas, J., Zeiner, P. S., . . . Wels, W. S. (2023). Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma. Neuro-oncology (Charlottesville, Va.), 25(11), 2058-2071. https://doi.org/10.1093/neuonc/noad087
Citácia podle Chicago (17th ed.)Burger, Michael C., et al. "Intracranial Injection of Natural Killer Cells Engineered with a HER2-targeted Chimeric Antigen Receptor in Patients with Recurrent Glioblastoma." Neuro-oncology (Charlottesville, Va.) 25, no. 11 (2023): 2058-2071. https://doi.org/10.1093/neuonc/noad087.
Citácia podľa MLA (8th ed.)Burger, Michael C., et al. "Intracranial Injection of Natural Killer Cells Engineered with a HER2-targeted Chimeric Antigen Receptor in Patients with Recurrent Glioblastoma." Neuro-oncology (Charlottesville, Va.), vol. 25, no. 11, 2023, pp. 2058-2071, https://doi.org/10.1093/neuonc/noad087.